raloxifene hydrochloride has been researched along with Disease Exacerbation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, F; Nan, XY; Ping, SH; Sun, Q; Tian, FM; Zhang, L; Zhou, Z | 1 |
| Acaroglu, E; Akel, I; Dede, O; Demirkiran, G; Marcucio, R; Yalcin, N | 1 |
| Greish, K; Pritchard, T; Rosengren, RJ; Taurin, S | 1 |
| Chow, CK; Eng-Wong, J; Galbo, CE; Orzano-Birgani, J; Prindiville, S; Venzon, D; Yao, J; Zujewski, JA | 1 |
| Eriguchi, R; Miura, S; Sato, Y; Umakoshi, J | 1 |
| Carlsten, H; Engdahl, C; Erlandsson, M; Gjertsson, I; Holmdahl, R; Islander, U; Jochems, C; Lagerquist, M; Ohlsson, C | 1 |
| Carlsten, H; Engdahl, C; Erlandsson, M; Holmdahl, R; Islander, U; Jochems, C; Lagerquist, M; Nandakumar, KS; Ohlsson, C | 1 |
| Furuya, T | 1 |
| Bracht, A; Campos, LB; Ishii-Iwamoto, EL; Martins-Maciel, ER; Salgueiro-Pagadigorria, CL | 1 |
| Fliegner, D; Penkalla, A; Petrov, G; Prelle, K; Regitz-Zagrosek, V; Schubert, C; Westphal, C | 1 |
| Hayes, DF | 1 |
| Braddon, J; Phillips, P | 1 |
| Erbagci, Z; Erkilic, S; Ozkur, M; Tuncel, A | 1 |
| Cohen, FJ; Glusman, J; Gradishar, W; Lu, Y; Sledge, GW; Vogel, C | 1 |
| Alexandersen, P; Bjarnason, NH; Byrjalsen, I; Christiansen, C; Haarbo, J; Kauffman, RF | 1 |
1 review(s) available for raloxifene hydrochloride and Disease Exacerbation
| Article | Year |
|---|---|
[Bone and calcium metabolism in patients with rheumatoid arthritis].
Topics: Animals; Arthritis, Rheumatoid; Bone and Bones; Calcium; Disease Models, Animal; Disease Progression; Estrogen Replacement Therapy; Estrogens; Female; Humans; Inflammation Mediators; Joints; Male; Menopause; Osteoporosis; Pregnancy; Pregnancy Complications; Raloxifene Hydrochloride | 2011 |
2 trial(s) available for raloxifene hydrochloride and Disease Exacerbation
| Article | Year |
|---|---|
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.
Topics: Breast Neoplasms; Disease Progression; Female; Follow-Up Studies; Humans; Incidence; Magnetic Resonance Imaging; Mammography; Premenopause; Prognosis; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Time Factors | 2008 |
Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunoradiometric Assay; Kidney Failure, Chronic; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2009 |
13 other study(ies) available for raloxifene hydrochloride and Disease Exacerbation
| Article | Year |
|---|---|
Raloxifene retards the progression of adjacent segmental intervertebral disc degeneration by inhibiting apoptosis of nucleus pulposus in ovariectomized rats.
Topics: Animals; Apoptosis; Bone Density; Disease Models, Animal; Disease Progression; Female; Intervertebral Disc Degeneration; Lumbar Vertebrae; Nucleus Pulposus; Osteoporosis; Ovariectomy; Postoperative Complications; Raloxifene Hydrochloride; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Spinal Fusion | 2021 |
Selective estrogen receptor modulation prevents scoliotic curve progression: radiologic and histomorphometric study on a bipedal C57Bl6 mice model.
Topics: Animals; Bone Density; Disease Models, Animal; Disease Progression; Female; Mice; Mice, Inbred C57BL; Raloxifene Hydrochloride; Scoliosis; Selective Estrogen Receptor Modulators; Tamoxifen | 2014 |
Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer.
Topics: Animals; Cell Line, Tumor; Chemistry, Pharmaceutical; Disease Progression; Humans; Male; Maleates; Mice; Micelles; Polystyrenes; Prostatic Neoplasms, Castration-Resistant; Raloxifene Hydrochloride; Tissue Distribution | 2016 |
Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis.
Topics: Animals; Arthritis, Experimental; Cartilage; Disease Models, Animal; Disease Progression; Estradiol; Estrogens; Female; Interleukin-6; Mice; Mice, Inbred DBA; Mice, Mutant Strains; Mutation; NADPH Oxidases; Osteoarthritis; Ovariectomy; Prevalence; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2010 |
Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis.
Topics: Animals; Antibodies; Arthritis, Experimental; Biomarkers; Bone Marrow; Collagen; Disease Progression; Estradiol; Female; Humans; Immunomodulation; Mice; Mice, Inbred DBA; Mice, Transgenic; Osteoporosis, Postmenopausal; Ovariectomy; Raloxifene Hydrochloride; Response Elements; Selective Estrogen Receptor Modulators; Transgenes | 2011 |
Raloxifene affects fatty acid oxidation in livers from ovariectomized rats by acting as a pro-oxidant agent.
Topics: Acyl Coenzyme A; Acyl-CoA Oxidase; Animals; Chemical and Drug Induced Liver Injury; Disease Progression; Estrogen Replacement Therapy; Fatty Acids; Fatty Liver; Female; Hydrogen Peroxide; Liver; Mitochondria, Liver; Ovariectomy; Oxidants; Oxidation-Reduction; Peroxidase; Peroxisomes; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators | 2013 |
Effects of estrogen, an ERĪ± agonist and raloxifene on pressure overload induced cardiac hypertrophy.
Topics: Animals; Aorta; Biomarkers; Cardiomegaly; Constriction, Pathologic; Disease Progression; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fibrosis; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Organ Size; Pressure; Raloxifene Hydrochloride; Survival Analysis; Systole; Ultrasonography; Uterus; Ventricular Function, Left | 2012 |
Playing the old piano: another tune for endocrine therapy?
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Clinical Trials as Topic; Diethylstilbestrol; Disease Progression; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Humans; Male; Neoplasms, Hormone-Dependent; Ovariectomy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Treatment Outcome | 2003 |
Osteoporosis--diagnosis, treatment and management.
Topics: Aged; Calcitriol; Diphosphonates; Disease Progression; Evidence-Based Medicine; Female; Humans; Life Style; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors | 2004 |
Progressive pigmentary purpura related to raloxifene.
Topics: Disease Progression; Female; Humans; Middle Aged; Purpura; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2005 |
Raloxifene can benefit prostate cancer.
Topics: Antineoplastic Agents, Hormonal; Disease Progression; Humans; Male; Prostatic Neoplasms; Raloxifene Hydrochloride | 2006 |
Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Confidence Intervals; Disease Progression; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Quality of Life; Raloxifene Hydrochloride; Receptors, Estrogen; Remission Induction; Safety; Selective Estrogen Receptor Modulators; Survival Rate; Tamoxifen | 2000 |
Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol, Dietary; Disease Progression; Estradiol; Female; Ovariectomy; Rabbits; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2001 |